CAMPYLOBACTER LEGIONELLA BARTONELLA

36
CAMPYLOBACTER LEGIONELLA BARTONELLA

description

CAMPYLOBACTER LEGIONELLA BARTONELLA. Campylobacter sp. OrganismSource(s)Human disease(s) C. coli Pigs, poultry, sheep,Gastroenteritis, bulls, birdssepticemia C. jejuni ssp. jejuni Poultry, pigs, bulls,Gastroenteritis, dogs, cats, birds, otherssepticemia, meningitis, - PowerPoint PPT Presentation

Transcript of CAMPYLOBACTER LEGIONELLA BARTONELLA

Page 1: CAMPYLOBACTER LEGIONELLA BARTONELLA

CAMPYLOBACTER

LEGIONELLA

BARTONELLA

Page 2: CAMPYLOBACTER LEGIONELLA BARTONELLA

Campylobacter sp.

Organism Source(s) Human disease(s)

C. coli Pigs, poultry, sheep, Gastroenteritis,bulls, birds septicemia

C. jejuni ssp. jejuni Poultry, pigs, bulls, Gastroenteritis,dogs, cats, birds, others septicemia, meningitis,

proctitis

C. jejuni ssp. doylei Humans Gastroenteritis,gastritis, septicemia

C. fetus ssp. fetus Cattle, sheep Septicemia,gastroenteritis,abortion, meningitis

Page 3: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics

• C. coli and C. fetus cause most human disease

• Transmitted through contaminated food, milk, or water

• Campylobacter does not multiply in food

• Person-to-person transmission is rare

Page 4: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics, cont.

• Seasonality in the U.S.; late summer-early fall peak

• Most common etiology of gastroenteritis in U.S.

• GI disease is typically self-limiting

• Post-infectious complications can include Guillain-Barré

Page 5: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis

Specimen collection

• No special requirements; stool and blood 1° specimens

• For stool delayed more than 2 hrs:Cary-Blair transportCampy thio (thio broth with 0.16% agar andvancomycin, trimethoprim, cephalothin,polymyxin B and amphotericin B)

Page 6: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Stool Culture

• Selective media and optimal conditions required

• Campy-CVA at UMHSBrucella agar base with antibiotics(cefoparazone, vancomycin, and

amphotericin B)5% sheep blood

• 42°C, microaerobic (10% CO2, 5% O2, 85% N2), 72 hrs

Page 7: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Blood Culture

• Can routinely be detected in commercial systems

• Some isolates may require 2 weeks to be detected

• Subcultures require incubation microaerobically

Page 8: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Microbiologic characteristics

• Growth at 42°C, microaerobically, grayish colonies

• Gram-negative bacillus; faintly staining

• Small rods, curved or seagull-winged

• Motile (darting on wet prep)

• Oxidase and catalase positive

• Reported as Campylobacter sp.

Page 9: CAMPYLOBACTER LEGIONELLA BARTONELLA

CDC Public Health Image Library (PHIL)

Page 10: CAMPYLOBACTER LEGIONELLA BARTONELLA

http://www.lf3.cuni.cz/ustavy/mikrobiologie/rep/caje.htm

Page 11: CAMPYLOBACTER LEGIONELLA BARTONELLA

Treatment

Antimicrobial Susceptibility Testing

• Standardized methods recently made available, but not routinely performed

Therapy

• Susceptible to macrolides, tetracyclines, aminoglycosides, and quinolones

• Erythromycin is drug of choice for severe GI illness, with Ciprofloxacin as an alternative

• Parenteral therapy required for systemic infections

Page 12: CAMPYLOBACTER LEGIONELLA BARTONELLA

Legionella sp.

Species isolated Species isolated fromfrom humans environment only

L. pneumophila, serotypes 1-15 L. cherriiL. micdadei L. erythraL. bozemanii L. gratianaL. dumoffii L. jamestowniensisL. feelei L. brunensisL. gormanii L. brunensisL. hackeliae L. fairfieldensisL. longbeachae L. santicrusisL. oakridgensisL. wadsworthii

• Over 40 species in the genus• L. pneumophila is the predominant pathogen

Page 13: CAMPYLOBACTER LEGIONELLA BARTONELLA

Epidemiology and pathogenesis

• Ubiquitous in environment; primarily aquatic habitat

• Widely distributed in natural and man-made environments

• Acquired environmentally, not person-to-person

• Exposure through inhalation of aerosolized organisms

• Can infect and multiply within free-living parasites- survival in environment

• Resist destruction following phagocytosis- survival in host

Page 14: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics

• Causative agent of Legionnaires’ Disease

- identified in 1976 following outbreak of severe respiratory illness at an American Legion convention in Philadelphia- organism did not grow on routine media- identification required months by CDC

• Fever, pneumonia; case-fatality rate of 10-20%

Page 15: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics, cont.

• Pontiac fever

- identified in Pontiac, MI- self-limiting, not-fatal respiratory infection

• Other infections

- wound abscesses, encephalitis, endocarditis

Page 16: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics, cont.

• Highest at-risk populations

ImmunocompromisedHeavy smokerOver age 60

• Same organisms may manifest itself differently in different individuals

• Also impacted by baseline immunity and dose

Page 17: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis

Specimen collection

• Respiratory tract specimens- sputum, BAL, pleural fluid

• Blood, tissue, biopsy material

Specimen processing

• Standard precautions (BSC)

• Concentration of dilute specimens

Page 18: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Direct detection

• DFA for organism in respiratory specimens

• Urine antigen testImmunochromatographic commercial testOnly detects L. pneumophila, serogroup 1

Page 19: CAMPYLOBACTER LEGIONELLA BARTONELLA

Legionella DFA Legionella Urine Ag

Page 20: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Culture

• Include Buffered Charcoal Yeast Extract (BCYE) AgarCharcoal to detoxify specimenCysteineInhibitors (polymixin B, anisomycin, cefamandole)

• Incubate 35 – 37°C, room air, for 7-10 days

Page 21: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Identification

• Small, gray-white to blue-green colonieswet, ground-glass speckling

• Gram stain yields thin, gram-negative rods

• ID of colony using FA reagents

• Report as Legionella sp.

Page 22: CAMPYLOBACTER LEGIONELLA BARTONELLA

http://www.rivm.nl/infectieziektenbulletin/bul1212/diagnose_en_preventie.html

http://reaannecy.free.fr/Documents/infectio/legionellose.htm

Colonies onBCYE

Gram stain

Page 23: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Serodiagnosis

• Turkey RBCs sensitized with Legionella antigens

• Set up in pools for screening purposes

• Incubate with patient serum and look for agglutination

• Test against individual antigens for type-specificity

• Only available at MDCH

Page 24: CAMPYLOBACTER LEGIONELLA BARTONELLA

Treatment

Antimicrobial Susceptibility Testing

• In vitro results do not correlate with clinical outcome, so not routinely performed

Therapy

• Azithromycin is effective against this and other causes of “atypical pneumonia”

• Fluoroquinolone for severely ill

• Penicillins, cephalosporins, and aminoglycosides are not effective

Page 25: CAMPYLOBACTER LEGIONELLA BARTONELLA

Bartonella sp.

Organism Resevoir Transmission Disease(s)

B. bacilliformis ?humans Sand flies Carrión’s disease

B. quintana ?humans Human body Trench fever, relapsing?rodents louse fever, bacteremia,

endocarditis, bacillaryangiomatosis,lymphadenopathy

B. henselae Domestic Cat bites or Cat-scratch disease,cats scratches bacteremia, endocarditis,

bacillary angiomatosis,peliosis hepatitis

• Bartonella currently includes 16 species, only 5 cause human disease

Page 26: CAMPYLOBACTER LEGIONELLA BARTONELLA

Epidemiology and pathogenesis

• Agent primarily of zoonotic infections

• Increasing in importance as a pathogen in immunocompromised hosts

• Pathogenesis is not well understood, but diseases caused by all species seem to be pathologically similar

Page 27: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics

• Trench fever (B. quintana)

- transmitted from infected body louse- affected many soldiers in battle- influenza-like headache, bone pain, splenomegaly, maculopapular rash

Page 28: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics

• Cat-scratch disease (B. henselae)

- papule or pustule develops at site of cat bite/scratch- regional tender lymphadenopathy develops in 1-7 weeks- disease ranges from chronic, self-limited adenopathy, to severe systemic illness

Page 29: CAMPYLOBACTER LEGIONELLA BARTONELLA

Los Angeles Co. West Vector Control Districthttp://www.lawestvector.org/bartonella.htm

Cat-scratch disease

http://www.uvp5.univ-paris5.fr/MICROBES/Diagnostic/Bartonella/Bartonella.asp

Page 30: CAMPYLOBACTER LEGIONELLA BARTONELLA

Clinical characteristics

• Bacillary angiomatosis (B. quintana and B. henselae)

- vascular proliferative disease (organisms stimulate angiogenesis)- small papules enlarge to form red – purple nodules- can occur on the skin surface, in subcutaneous tissue, or in visceral organs- primarily seen in HIV+; some reports in transplant patients

Page 31: CAMPYLOBACTER LEGIONELLA BARTONELLA

Bacillary angiomatosis

http://www.emedicine.com/derm/topic44.htm

Page 32: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis

Specimen collection

• Blood, tissue, biopsy material

Direct detection

• Histopathologic detection in tissue using Warthin- Starry silver stain

• PCR for detection in tissue and body fluids

Page 33: CAMPYLOBACTER LEGIONELLA BARTONELLA

Demonstration of Bartonella henselae in cardiac valve of a patient with blood culture-negative endocarditis. The bacilli appear as black granulations (Warthin Starry, original magnification X250).

http://www.cdc.gov/ncidod/eid/vol8no2/01-0141-G2.htm

Page 34: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Culture

• Fastidious organism; culture infrequently performed

Page 35: CAMPYLOBACTER LEGIONELLA BARTONELLA

Laboratory Diagnosis, cont.

Serodiagnosis

• Main method for diagnosis

• IFA using antigen prepared from co-cultures

• HIV-infected patients may not mount an antibody response to infection

Page 36: CAMPYLOBACTER LEGIONELLA BARTONELLA

Treatment

Antimicrobial Susceptibility Testing

• In vitro testing is difficult because of limited availability of strains and fastidious nature of organism

Therapy

• Aminoglycosides, beta-lactam agents, erythromycin, and doxycycline

• At-risk individuals should avoid exposures to cats